**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no
implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information
is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Alzheimer Society of Canada
Address:
20 Eglinton Avenue West, Suite 1600
Ontario, Intl M4R 1K8
Canada
Phone: (41-6) -488-8772
Fax: (41-6) -322-6656
800 Number: (80-0) -616-8816
TDD: --
Email Address: info@alzheimer.ca
The Alzheimer Society of Canada is a non-profit Canadian health organization that is dedicated to providing a nationwide network of services to help Canadians affected by Alzheimer's disease, a degenerative neurological disease characterized by progressive deterioration of cognitive processes and memory (dementia). Affected individuals experience progressive memory failure; confusion and disorientation; changes in mood, behavior, and personality; speech difficulties; and other symptoms and findings. The Alzheimer Society of Canada was founded in 1978 and has 10 provincial societies across Canada. The society's objectives include alleviating the personal and social consequences of Alzheimer's disease, supporting those who are caring for people with the disease, promoting public understanding and awareness, and funding biomedical, social, and psychological research. The society offers a variety of programs and services including conducting an annual national awareness program, providing care guidelines for caregivers, and running Safely Home TM.
Chapters: 10
Website: http://www.alzheimer.ca
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted
by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to
the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes
without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on
an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source
(NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed
versions are strictly prohibited.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.